This week, the GOLD team discusses key articles and themes from the latest magazine, drilling down into topics such as what pharma can learn from the tech giants, the industry's response to Roe v. Wade and the delicate balance of biotech success, to give listeners some exclusive context and insights on three fascinating stories affecting the industry today.
If you're interested in learning more about the topic areas discussed in this episode, check out the following content:
Following in the footsteps of tech giants https://www.emg-gold.com/post/following-in-the-footsteps-of-tech-giants
Pharma's response to Roe v. Wade https://www.emg-gold.com/post/pharma-s-response-to-roe-v-wade
Is the biotech boom on thin ice? https://www.emg-gold.com/post/is-the-biotech-boom-on-thin-ice
Decentralised clinical trials: going green https://www.emg-gold.com/post/decentralised-clinical-trials-going-green
